Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,754,304
-
Share change
-
+626,613
-
Total reported value
-
$167,435,000
-
Price per share
-
$7.05
-
Number of holders
-
57
-
Value change
-
+$5,382,130
-
Number of buys
-
27
-
Number of sells
-
36
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q2 2021
As of 30 Jun 2021 SATSUMA PHARMACEUTICALS INC - COM (STSA) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,754,304 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, COMMODORE CAPITAL LP, TPG Group Holdings (SBS) Advisors, Inc., SAMLYN CAPITAL, LLC, Vivo Capital, LLC, CITADEL ADVISORS LLC, Ghost Tree Capital, LLC, AMERIPRISE FINANCIAL INC, and VANGUARD GROUP INC.
This table shows 57 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.